Many initiatives are ongoing to implement PGx knowledge and associated guidelines in clinical practise as a way to introduce personalised medicine. We believe payor platforms have a critical responsibility in PGx, to establish a uniform and full integration in the healthcare system and to ensure that solutions based on PGx will be reimbursed and optimised for larger populations.

Our solution for healthcare platforms offers a personalised treatment advice based on current guidelines for the use of genetic biomarkers, the best solution on a patient by patient basis without disclosing genetic information. This way we can help to reduce liability risk for insurance platforms within their business activity without having to access sensitive information directly.